Related Experiment Video
Updated: Feb 8, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Aβ inhibits mesenchymal stem cell-pericyte transition through MAPK pathway
Lixia Xu1, Jialin Li2, Zhongqiu Luo2
1Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin, China.
Abstract:
Multiple independent reports have demonstrated pericyte loss in both the hippocampus and cortex in human Alzheimer's disease (AD). The differentiation and recruitment of pericytes are the essential steps in vasculature development. However, the role of amyloid beta (Aβ) in pericyte differentiation has not yet been fully elucidated. In this study, we investigated the interaction between Aβ and differentiation of mesenchymal stem cells (MSCs) toward pericytes in culture. Our results showed that mice overexpressing Aβ-precursor protein (APP/PS1) exhibited the loss of pericytes compared with the control group mice, evidenced by the lack of desmin expression in the cortex of 12-month-old mice. Interestingly, we further found that both Aβ40 and Aβ42 inhibited the expressions of pericyte markers (α-SMA, desmin, and PDGFRβ) in cultured MSCs which can be differentiated into mature pericytes. Mechanistically, the inhibitory effects of Aβs on MSC-pericyte transition is mediated by the activation of the ERK1/2 MAPK signal pathway. These new insights into the roles of Aβ in pericyte differentiation may help to develop more effective strategies for the treatment of AD.
Insights
Amyloid beta (Aβ) impairs pericyte differentiation, a crucial step in blood vessel formation, potentially contributing to Alzheimer's disease (AD) pathology. This study reveals Aβ inhibits pericyte marker expression via the ERK1/2 MAPK pathway.
Area of Science:
- Neuroscience
- Cell Biology
- Vascular Biology
Background:
- Pericyte loss is a hallmark of human Alzheimer's disease (AD) in the brain's hippocampus and cortex.
- Pericyte differentiation and recruitment are vital for blood vessel development.
- The specific impact of amyloid beta (Aβ) on pericyte differentiation remains unclear.
Purpose of the Study:
- To investigate the interaction between Aβ and the differentiation of mesenchymal stem cells (MSCs) into pericytes.
- To elucidate the mechanisms by which Aβ affects pericyte differentiation.
Main Methods:
- Examined pericyte markers (desmin) in the cortex of APP/PS1 mice overexpressing Aβ.
- Assessed the effect of Aβ40 and Aβ42 on pericyte marker expression (α-SMA, desmin, PDGFRβ) in cultured MSCs.
- Investigated the role of the ERK1/2 MAPK signaling pathway in mediating Aβ's effects.
Main Results:
- APP/PS1 mice showed significant pericyte loss compared to controls, indicated by reduced desmin expression.
- Both Aβ40 and Aβ42 inhibited the expression of key pericyte markers in differentiating MSCs.
- Aβ-induced inhibition of MSC-to-pericyte transition was mediated by the activation of the ERK1/2 MAPK pathway.
Conclusions:
- Amyloid beta directly inhibits the differentiation of mesenchymal stem cells into pericytes.
- The ERK1/2 MAPK pathway is a key mediator of Aβ's detrimental effects on pericyte differentiation.
- Understanding Aβ's role in pericyte differentiation may offer new therapeutic targets for Alzheimer's disease.
Related Concept Videos
Mesenchymal Stem Cells
Feedback Inhibition
Adult Stem Cells
Phase Transitions
MAPK Signaling Cascades
Properties of Transition Metals

